Correlation Between Axsome Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Axsome Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for Axsome Therapeutics and Apellis Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Axsome and Apellis is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 1.28 times more return on investment than Apellis Pharmaceuticals. However, Axsome Therapeutics is 1.28 times more volatile than Apellis Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 8,478 in Axsome Therapeutics on December 28, 2024 and sell it today you would earn a total of 3,699 from holding Axsome Therapeutics or generate 43.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Axsome Therapeutics vs. Apellis Pharmaceuticals
Performance |
Timeline |
Axsome Therapeutics |
Apellis Pharmaceuticals |
Axsome Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Axsome Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite Axsome Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |